8FDA. Strategic Plan for Risk Communication[ EB/OL]. [2012 - 02 - 27]. http://www, fda. gov/AbuutFDA/Reports-Manuals- Forms/Reports/ucm183673. htm,.
9NISSEN SE, WOLSKI K. Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes[J].N Engl J Med, 2007, 356(24) : 2457 -2471.
10FDA. Guidance Drug Safety Information-FDA' s Communication to the Public [ EB/OL ]. [ 2009 -05 ]. http://www, fda. gov/ cder/guidance/index, htm.
